Cécile Blanc‐Fournier

1.1k total citations
26 papers, 330 citations indexed

About

Cécile Blanc‐Fournier is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Cécile Blanc‐Fournier has authored 26 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Cécile Blanc‐Fournier's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Medical Imaging Techniques and Applications (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Cécile Blanc‐Fournier is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Medical Imaging Techniques and Applications (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Cécile Blanc‐Fournier collaborates with scholars based in France, Luxembourg and United States. Cécile Blanc‐Fournier's co-authors include Mélanie Briand, Florence Giffard, Nicolas Aide, Laurent Poulain, Charline Lasnon, Soizic Dutoit, Émilie Brotin, Stéphanie Lheureux, Sabrina Kellouche and Johanne Leroy‐Dudal and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Annals of Oncology.

In The Last Decade

Cécile Blanc‐Fournier

26 papers receiving 326 citations

Peers

Cécile Blanc‐Fournier
Min-Ki Seong South Korea
Cécile Blanc‐Fournier
Citations per year, relative to Cécile Blanc‐Fournier Cécile Blanc‐Fournier (= 1×) peers Min-Ki Seong

Countries citing papers authored by Cécile Blanc‐Fournier

Since Specialization
Citations

This map shows the geographic impact of Cécile Blanc‐Fournier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Blanc‐Fournier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Blanc‐Fournier more than expected).

Fields of papers citing papers by Cécile Blanc‐Fournier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Blanc‐Fournier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Blanc‐Fournier. The network helps show where Cécile Blanc‐Fournier may publish in the future.

Co-authorship network of co-authors of Cécile Blanc‐Fournier

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Blanc‐Fournier. A scholar is included among the top collaborators of Cécile Blanc‐Fournier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Blanc‐Fournier. Cécile Blanc‐Fournier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elie, Nicolas, Pierre‐Marie Morice, Louis‐Bastien Weiswald, et al.. (2025). Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids. Laboratory Investigation. 105(4). 104097–104097. 1 indexed citations
2.
Agniel, Rémy, Florence Giffard, Cécile Blanc‐Fournier, et al.. (2024). Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins. Experimental Cell Research. 441(1). 114155–114155. 6 indexed citations
3.
Silva, Angélique Da, Alison Johnson, Cécile Blanc‐Fournier, et al.. (2022). HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer. BMC Cancer. 22(1). 1081–1081. 12 indexed citations
4.
Elie, Nicolas, Florence Giffard, Cécile Blanc‐Fournier, et al.. (2022). Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology. Frontiers in Oncology. 12. 931035–931035. 4 indexed citations
5.
Aide, Nicolas, Laurent Poulain, Nicolas Elie, et al.. (2021). A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers. EJNMMI Research. 11(1). 11–11. 10 indexed citations
7.
Richard, Nicolas, Cécile Blanc‐Fournier, Frédéric Bibeau, et al.. (2021). Contribution of the IdyllaTM System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of EGFR Mutations. Current Oncology. 28(6). 4432–4445. 9 indexed citations
8.
Vernon, Mégane, Bernard Lambert, Matthieu Meryet‐Figuière, et al.. (2020). Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids. Molecular Cancer Therapeutics. 19(7). 1506–1519. 23 indexed citations
9.
Bascetin, Rümeyza, Cécile Blanc‐Fournier, Charlotte Vendrely, et al.. (2020). A biomimetic model of 3D fluid extracellular macromolecular crowding microenvironment fine-tunes ovarian cancer cells dissemination phenotype. Biomaterials. 269. 120610–120610. 20 indexed citations
10.
Sauvage, Félix, Elias Fattal, Walhan Alshaer, et al.. (2018). Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice. Cancer Letters. 432. 103–111. 17 indexed citations
11.
Ciappuccini, Renaud, Cédric Desmonts, Idlir Licaj, et al.. (2018). Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck 18FDG PET/CT imaging in differentiated thyroid cancer. EJNMMI Research. 8(1). 104–104. 7 indexed citations
12.
Meryet‐Figuière, Matthieu, Charlotte Lecerf, Jean‐Luc Coll, et al.. (2017). Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route. Oncology Reports. 38(4). 1949–1958. 5 indexed citations
13.
Brachet, Pierre-Emmanuel, Michel Fabbro, Alexandra Léary, et al.. (2017). A GINECO phase II study of Navitoclax (ABT 263) in women with platinum resistant/refractory recurrent ovarian cancer (ROC). Annals of Oncology. 28. v347–v347. 4 indexed citations
14.
Lasnon, Charline, Audrey Emmanuelle Dugué, Mélanie Briand, et al.. (2014). NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System. Molecular Imaging and Biology. 17(3). 403–412. 14 indexed citations
15.
N’Diaye, Monique, Stéphanie Lheureux, Soizic Dutoit, et al.. (2013). Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis. APOPTOSIS. 18(4). 492–508. 35 indexed citations
16.
Agniel, Rémy, Sabrina Kellouche, Cédric R. Picot, et al.. (2013). Ovarian cancer ascites-derived vitronectin and fibronectin: Combined purification, molecular features and effects on cell response. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(10). 4885–4897. 22 indexed citations
17.
Lheureux, Stéphanie, et al.. (2013). Cas rare d’une tumeur à deux inflexions morphologiques chez une patiente suivie pour une maladie de Crohn. Annales de Pathologie. 33(2). 122–124. 1 indexed citations
18.
Bertucci, François, Pascal Finetti, Henri Roché, et al.. (2012). Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients. Annals of Oncology. 24(3). 625–632. 27 indexed citations
19.
Lheureux, Stéphanie, Sophie Krieger, B. Weber, et al.. (2012). Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile. International Journal of Gynecological Cancer. 22(9). 1483–1488. 30 indexed citations
20.
Michels, Jean-Jacques & Cécile Blanc‐Fournier. (2008). Quel diagnostic l’anatomopathologiste peut-il porter en présence d’une thyroïdite sclérosante ?. Annales de Pathologie. 28(4). 263–267. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026